These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 6358588)

  • 21. Remodelling of zero-stress state of small intestine in streptozotocin-induced diabetic rats. Effect of gliclazide.
    Zhao J; Sha H; Zhou S; Tong X; Zhuang FY; Gregersen H
    Dig Liver Dis; 2002 Oct; 34(10):707-16. PubMed ID: 12469798
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differential changes of adrenoceptor- and muscarinic receptor-linked prostacyclin synthesis by the aorta and urinary bladder of the diabetic rat.
    Jeremy JY; Thompson CS; Mikhailidis DP
    Br J Pharmacol; 1993 Apr; 108(4):1131-6. PubMed ID: 8485622
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effects of gliclazide on platelet function in patients with diabetes mellitus.
    Violi F; De Mattia GC; Alessandri C; Perrone A; Vezza E
    Curr Med Res Opin; 1982; 8(3):200-3. PubMed ID: 7128193
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Differential effects of megavitamin E on prostacyclin and thromboxane synthesis in streptozotocin-induced diabetic rats.
    Gilbert VA; Zebrowski EJ; Chan AC
    Horm Metab Res; 1983 Jul; 15(7):320-5. PubMed ID: 6350138
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of gliclazide on the functional response to calcium in diabetic rat heart.
    Shinzato T; Shimabukuro M; Higa S; Nagamine F; Murakami K; Takasu N
    Gen Pharmacol; 1996 Apr; 27(3):471-5. PubMed ID: 8723529
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Drug interactions of gliclazide and other sulfonylureas in protein binding in vitro and in hypoglycemic effect in rats.
    Fujii T; Nakamura K; Furukawa H; Watanabe M; Kuwashima J; Miyazaki H; Kawashima K; Kuzuya T
    Arzneimittelforschung; 1983; 33(11):1535-7. PubMed ID: 6686448
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Hypoglycemic agents of the 2d generation].
    Giulietti M
    Clin Ter; 1978 Jul; 86(2):179-81. PubMed ID: 743858
    [No Abstract]   [Full Text] [Related]  

  • 28. Vascular action of the hypoglycaemic agent gliclazide in diabetic rabbits.
    Pagano PJ; Griswold MC; Ravel D; Cohen RA
    Diabetologia; 1998 Jan; 41(1):9-15. PubMed ID: 9498623
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Studies on the hypoglycaemic action of gliclazide, a sulphonyl-urea drug [proceedings].
    Furman BL; Musbah MO
    J Pharm Pharmacol; 1977 Dec; 29 Suppl():55P. PubMed ID: 22687
    [No Abstract]   [Full Text] [Related]  

  • 30. Microvascular permeability with sulfonylureas in normal and diabetic hamsters.
    Bouskela E; Cyrino FZ; Conde CM; Garcia AA
    Metabolism; 1997 Dec; 46(12 Suppl 1):26-30. PubMed ID: 9439555
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effect of experimental diabetes on prostacyclin production by tissues from pregnant rats.
    El Tahir KE; Williams KI; Betteridge DJ
    Prostaglandins Leukot Med; 1982 May; 8(5):429-35. PubMed ID: 7048333
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Renin-angiotensin system and prostacyclin biosynthesis in streptozotocin diabetic rats.
    Funakawa S; Okahara T; Imanishi M; Komori T; Yamamoto K; Tochino Y
    Eur J Pharmacol; 1983 Oct; 94(1-2):27-33. PubMed ID: 6360695
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Gliclazide inhibits diabetic neuropathy irrespective of blood glucose levels in streptozotocin-induced diabetic rats.
    Qiang X; Satoh J; Sagara M; Fukuzawa M; Masuda T; Miyaguchi S; Takahashi K; Toyota T
    Metabolism; 1998 Aug; 47(8):977-81. PubMed ID: 9711995
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Inhibitory effect of gliclazide on platelet adhesiveness and aggregation in alloxan diabetic rabbits (author's transl)].
    Kuwashima J; Tsuboi T; Komiya M; Fujitani B; Nakamura K; Maeda J; Kaneko H; Yoshida K; Shimizu M
    Yakugaku Zasshi; 1979 Jan; 99(1):59-64. PubMed ID: 430345
    [No Abstract]   [Full Text] [Related]  

  • 35. Effects of a thromboxane A2-receptor antagonist, a thromboxane synthetase inhibitor and aspirin on prostaglandin I2 production in endothelium-intact and -injured aorta of guinea pigs.
    Higo K; Karasawa A
    Jpn J Pharmacol; 1994 Dec; 66(4):471-9. PubMed ID: 7723224
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of insulin treatment on prostacyclin in experimental diabetes.
    Harrison HE; Reece AH; Johnson M
    Diabetologia; 1980 Jan; 18(1):65-8. PubMed ID: 6988267
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Simulating the diabetic environment modifies in vitro prostacyclin synthesis.
    Jeremy JY; Mikhailidis DP; Dandona P
    Diabetes; 1983 Mar; 32(3):217-21. PubMed ID: 6337900
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The influence of oral hypoglycaemic sulfonyl ureas on prostacyclin release by the rat thoracic aorta.
    el Tahir KE; Ali AE; Abu Nasif MA; Ageel AM; Gadkarim EA
    Arch Int Pharmacodyn Ther; 1986 Sep; 283(1):134-40. PubMed ID: 3099669
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of gliclazide--a new antidiabetic agent--on blood platelet function in vitro and in vivo.
    Arfors KE; Bergqvist D; Tangen O
    Ups J Med Sci; 1980; 85(1):74-83. PubMed ID: 7385462
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effects of gliclazide and other sulfonylureas on low-density lipoprotein oxidation in vitro.
    O'Brien RC; Luo M
    Metabolism; 1997 Dec; 46(12 Suppl 1):22-5. PubMed ID: 9439554
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.